Skip to content

Evaluation of On-eye Optical Performances of the RMY-100 Lens

Evaluation of On-eye Optical Performances of the RMY-100 Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03670277
Enrollment
28
Registered
2018-09-13
Start date
2018-08-22
Completion date
2019-02-19
Last updated
2025-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Acuity

Brief summary

This is a two-arm parallel, non-masked, bilateral, non-dispensing study with one Test arm and one concurrent, non-randomized Control arm to evaluate the one-eye optical performances of the test soft contact lens and compare with eyes treated with orthokeratology.

Interventions

DEVICEetafilcon A

Test Soft Contact Lens

DEVICEHabitual Orthokeratology Lenses

CONTROL

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Potential subjects must satisfy all of the following criteria to be enrolled in the study: 1. Pediatric subjects (\<18 years old) must read (or be read to), understand, and sign the Statement of Information and Assent and receive a fully executed copy of the form. 2. Adult subjects (≥18 years old) and parent(s) or legal guardian(s) of pediatric subjects must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form. 3. Appear able and willing to adhere to the instructions set forth in this clinical protocol. 4. Between 7 and 25 years of age (inclusive). 5. Have normal eyes (i.e., no ocular medications or infections of any type). 6. Vertex-corrected distance subjective best-sphere refraction must be between -1.00D and -5.00D (inclusive) in each eye. 7. Cylindrical refraction must be 1.00D or less in each eye, by subjective sphero-cylindrical refraction. 8. Have sphero-cylindrical best-corrected visual acuity of 20/25 or better in each eye. Below inclusion criterion is for subjects to be enrolled to the Control group only: 9. Are existing orthokeratology patients whose current treatment has been stabilized for at least 1 months and with complete pre-treatment record, e.g., spherocylindrical refraction and corneal topography. Pre-treatment wavefront aberration measures are preferred by not required.

Exclusion criteria

* Potential subjects who meet any of the following criteria will be excluded from participating in the study: 1. Currently pregnant or lactating. 2. Any systemic allergies, infectious disease (e.g., hepatitis, tuberculosis), autoimmune disease (e.g., rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with contact lens wear and/or participation in the study. 3. Use of systemic medications (e.g., chronic steroid use) that are known to interfere with contact lens wear and/or participation in the study. 4. Any current use of ocular topical medication (occasional use of re-wetting drops is allowed). 5. Any previous or planned ocular or intraocular surgery, including refractive surgery. 6. Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment. 7. Employee or their children/relatives of investigational clinic (e.g., Investigator, Coordinator, Technician). 8 . Any ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to, aphakia, uveitis, ocular hypertension, glaucoma, severe keratoconjunctivitis sicca, history of recurrent corneal erosions, keratoconus, keratoconus suspect, pellucid marginal degeneration, entropion, ectropion, extrusions, chalazia, and recurrent styes. 9 . Any Grade 3 or greater slit lamp findings (eg, edema, corneal neovascularization, corneal staining, tarsal abnormalities, and conjunctival injection) on the FDA scale. 10 . Any ocular abnormality that is contraindicated contact lens wear. 11 . Any corneal scar within central 5mm 12 . Binocular vision abnormality, intermittent strabismus or strabismus. Below

Design outcomes

Primary

MeasureTime frameDescription
Distance Spherical Aberration (Z4, 0)Up to Post Lens Fitting EvaluationSpherical aberration (Z4, 0) for a 5-mm pupil was measured by an aberrometer (COAS by AMO) with a distant viewing target at 4 m at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.
Near Spherical Aberration (Z4, 0)Up to Post Lens Fitting EvaluationSpherical aberration (Z4, 0) for a 5 mm pupil was measured by an aberrometer (COAS by AMO) with a near view target at 25 cm. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Secondary

MeasureTime frameDescription
Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.Up to Post Lens Fitting EvaluationDistance off-axis refractions were measured by an open-field autorefractor (WAM-5500 by Grand Seiko) with distant viewing targets at 4 m and ±10°, ±20°, and ±30° off axis. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.
Near Off-axis Refraction at ±30° Retinal Eccentricities.Up to Post Lens Fitting EvaluationNear off-axis refractions were measured by an open-field autorefractor (WAM-5500 by Grand Seiko) with near viewing targets at 25 cm and ±30° off-axis. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Countries

Canada

Participant flow

Recruitment details

A total of 28 subjects were enrolled into this study at 1 clinical site. Of those enrolled, 20 subjects in the test arm were dispensed a study lens while, 8 subjects in the control arm were not dispensed, all 28 subjects who were enrolled have completed the study.

Participants by arm

ArmCount
Test
Subjects were fit with the Test lens at Visit 2 of the study
20
Control
Existing Orthokeratology patients who have \>=5 mm pupil size at Visit 1 Baseline.
8
Total28

Baseline characteristics

CharacteristicTestControlTotal
Age, Continuous17.9 years
STANDARD_DEVIATION 3.82
16.8 years
STANDARD_DEVIATION 4.62
17.6 years
STANDARD_DEVIATION 4.01
Race/Ethnicity, Customized
Asian
6 participants7 participants13 participants
Race/Ethnicity, Customized
Other
4 participants1 participants5 participants
Race/Ethnicity, Customized
White
10 participants0 participants10 participants
Region of Enrollment
Canada
20 participants8 participants28 participants
Sex: Female, Male
Female
14 Participants6 Participants20 Participants
Sex: Female, Male
Male
6 Participants2 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 8
other
Total, other adverse events
0 / 200 / 8
serious
Total, serious adverse events
0 / 200 / 8

Outcome results

Primary

Distance Spherical Aberration (Z4, 0)

Spherical aberration (Z4, 0) for a 5-mm pupil was measured by an aberrometer (COAS by AMO) with a distant viewing target at 4 m at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Time frame: Up to Post Lens Fitting Evaluation

Population: All subjects who were administered any test article excluding subjects who dropped out prior to administering any test article. At least one observation was recorded.

ArmMeasureValue (MEAN)Dispersion
TestDistance Spherical Aberration (Z4, 0)0.350 micronStandard Deviation 0.066
ControlDistance Spherical Aberration (Z4, 0)0.364 micronStandard Deviation 0.212
Comparison: This was a pilot study for assessing the investigational test articles. As such, the sample size was not determined based on any power analysis with regard to the primary endpoint.95% CI: [-0.081, 0.056]Mixed Models Analysis
Primary

Near Spherical Aberration (Z4, 0)

Spherical aberration (Z4, 0) for a 5 mm pupil was measured by an aberrometer (COAS by AMO) with a near view target at 25 cm. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Time frame: Up to Post Lens Fitting Evaluation

Population: All subjects who were administered any test article excluding subjects who dropped out prior to administering any test article. At least one observation was recorded.

ArmMeasureValue (MEAN)Dispersion
TestNear Spherical Aberration (Z4, 0)0.300 micronStandard Deviation 0.061
ControlNear Spherical Aberration (Z4, 0)0.272 micronStandard Deviation 0.144
Comparison: This was a pilot study for assessing the investigational test articles. As such, the sample size was not determined based on any power analysis with regard to the primary endpoint.95% CI: [-0.037, 0.1]Mixed Models Analysis
Secondary

Distance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.

Distance off-axis refractions were measured by an open-field autorefractor (WAM-5500 by Grand Seiko) with distant viewing targets at 4 m and ±10°, ±20°, and ±30° off axis. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Time frame: Up to Post Lens Fitting Evaluation

Population: All subjects who were administered any test article excluding subjects who dropped out prior to administering any test article. At least one observation was recorded.

ArmMeasureGroupValue (MEAN)Dispersion
TestDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.-300.3502 DiopterStandard Deviation 3.79171
TestDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.-20-1.1344 DiopterStandard Deviation 1.39215
TestDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.-10-0.3786 DiopterStandard Deviation 0.94009
TestDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.+10-1.4402 DiopterStandard Deviation 1.2224
TestDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.+20-1.9654 DiopterStandard Deviation 1.22837
TestDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.+30-0.1098 DiopterStandard Deviation 3.76589
ControlDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.+20-4.4656 DiopterStandard Deviation 2.07377
ControlDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.-30-3.0756 DiopterStandard Deviation 1.66232
ControlDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.+10-1.7429 DiopterStandard Deviation 1.16422
ControlDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.-20-2.4579 DiopterStandard Deviation 1.9126
ControlDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.+30-2.5638 DiopterStandard Deviation 2.61755
ControlDistance Off-axis Refraction at ±10°, ±20°, and ±30° Retinal Eccentricities.-10-0.4444 DiopterStandard Deviation 0.53691
Comparison: At -30°95% CI: [2.557, 4.248]Mixed Models Analysis
Comparison: At +30°95% CI: [1.585, 3.277]Mixed Models Analysis
Secondary

Near Off-axis Refraction at ±30° Retinal Eccentricities.

Near off-axis refractions were measured by an open-field autorefractor (WAM-5500 by Grand Seiko) with near viewing targets at 25 cm and ±30° off-axis. at the Baseline and post lens fitting. The Control Group only had 1 study Visit that record Baseline measurements, no intervention from the sponsor was implemented for this group, therefore data was collected on a bare eye. The Test group was fitted with the study lens at Visit 2 and data was collected with the Test lens on eye.

Time frame: Up to Post Lens Fitting Evaluation

Population: All subjects who were administered any test article excluding subjects who dropped out prior to administering any test article. At least one observation was recorded.

ArmMeasureGroupValue (MEAN)Dispersion
TestNear Off-axis Refraction at ±30° Retinal Eccentricities.+30-3.6046 DiopterStandard Deviation 3.37323
TestNear Off-axis Refraction at ±30° Retinal Eccentricities.-30-2.3463 DiopterStandard Deviation 3.1356
ControlNear Off-axis Refraction at ±30° Retinal Eccentricities.-30-5.3558 DiopterStandard Deviation 2.49516
ControlNear Off-axis Refraction at ±30° Retinal Eccentricities.+30-4.9883 DiopterStandard Deviation 3.77839
Comparison: At -30°95% CI: [1.854, 4.225]Mixed Models Analysis
Comparison: At +30°95% CI: [0.228, 2.599]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026